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 Patient: Male, 69
 Final Diagnosis: Coronary artery disease
 Symptoms: Angina pectoris
 Medication: Aspirin
 Clinical Procedure: Coronary artery bypass surgery
 Specialty: Cardiology
 Objective: Unusual clinical course
 Background: A preponderance of evidence supports short-term aspirin usage to reduce transiently increased cardiovascu-
lar risk in clinical conditions that promote acute myocardial ischemia.
 Case Report: We report on the case of a 69-year-old male of Muslim Indian heritage with multiple cardiovascular risk factors 
who experienced the onset of angina pectoris while fasting for Ramadan for more than 16 hours daily for 30 
days in July 2015. While symptom free for 2 months on medical management after ending his fast, he under-
went quadruple coronary artery bypass surgery for severe 4-vessel disease following an acute anterior myo-
cardial infarction. A percutaneous coronary intervention with stent placement was subsequently required for 
persistent myocardial ischemia on stress-MIBI testing due to occlusion of the graft to left anterior descending 
artery. Presently asymptomatic, he decided to forgo fasting for Ramadan in June 2016.
 Conclusions: Based on this case, measures for primary cardiovascular prevention among the 1.2 billion susceptible males 
at similar high short-term cardiac risk while fasting for Ramadan are proposed. The value of aspirin for at-
tenuating high short-term cardiovascular risk in clinical conditions conferring transient inflammatory stress is 
considered.
  Low-dose aspirin usage at evening meals while fasting for Ramadan is prudent for primary cardiovascular pro-
tection of males who may have non-obstructive coronary atherosclerosis to mitigate the risk for rupture of po-
tentially vulnerable plaques. Based in part on conclusive evidence for protection of middle-aged males from 
first myocardial infarction in a randomized prospective primary prevention trial, this measure is concordant with 
recommendations from sub-specialty societies for primary cardiovascular prevention for persons at above-av-
erage risk demonstrated by validated biomarkers and from the United States Preventive Services Task Force.
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Background
While observing Ramadan is regarded as safe for cardiac pa-
tients, participation is potentially contra-indicated during unsta-
ble angina as extensive fasting may exacerbate acute myocar-
dial ischemia. Based upon such a case, we explore a potential 
strategy for primary prevention of acute cardiac events in sus-
ceptible males while fasting for Ramadan.
Case Report
A 69-year-old male of Muslim Indian heritage with borderline hy-
pertension, hyperlipidemia, and type 2 diabetes mellitus expe-
rienced the onset of angina pectoris while fasting for Ramadan 
in July 2015. This non-smoking, non-drinking vegetarian with a 
body mass index of 25 experienced the onset of substernal chest 
pain while mowing his lawn during this holiday, which entailed 
fasting for 16 hours daily for 30 days. During Ramadan, he not-
ed exertional angina and dyspnea especially when walking up 
inclines, which caused him to walk more slowly. An exercise test 
with imaging demonstrated EKG changes in the high lateral leads 
and moderate inferior and inferolateral ischemia. Coronary an-
giography demonstrated a 40% coronary lesion in the left main 
coronary artery, a 50% ostial lesion of the left anterior descend-
ing coronary artery, a focal 50% stenosis of the left circumflex, 
and a focal 70% lesion of the right coronary artery. Medical man-
agement was pursued given the low-risk stress test findings
With medical management including low-dose aspirin, atorvas-
tatin 80 mg PO Q PM, metoprolol succinate extended release 
50 mg PO BID, and lisinopril 5 mg PO QD in accordance with 
NICE clinical guidelines [1], he became entirely symptom free 
after cessation of fasting after Ramadan. His angina in fact en-
tirely resolved for several months until he suffered an inferior 
myocardial infarction. At that time, he had a new thrombotic 
occlusion of the right coronary artery and required a four-ves-
sel bypass with a left internal mammary artery (LIMA) to the 
left anterior descending artery (LAD), saphenous vein graft to 
the posterior descending artery (PDA), saphenous vein graft to 
the obtuse marginal, and a saphenous vein graft to the ramus 
intermedius. He was then treated with dual anti-platelet ther-
apy including the addition of clopidogrel 75 mg PO QD to his 
prior regimen of statins, beta-blockers, and an ACE inhibitor. 
Resuming family life and his career as a professor of electrical 
engineering, he now participates in cardiac rehabilitation but 
elected to refrain from fasting during Ramadan in June 2016.
Discussion
The complexity of this patient’s clinical course notwithstand-
ing, his case provides an opportunity to review the impact of 
fasting for Ramadan on the risk for cardiovascular disease as 
reported in recent studies. While such observance has been 
associated with improved scores on Framingham-based risk 
factors and is regarded as safe for patients with stable coro-
nary heart disease [2,3], unstable angina [UA] is a contra-in-
dication as the pathophysiological stress of extended fasting 
may exacerbation acute myocardial ischemia [4]. Compromised 
pre-load due to dehydration and increased myocardial oxygen 
demand during intense emotional excitement may exacerbate 
risk for acute cardiac events including sudden death [5,6].
In this case, the patient who at the time had stable coronary 
disease developed exertional angina while fasting, and then 
the angina entirely resolved after fasting. We believe that this 
example raises the need to be aware of fasting-related angi-
na for patients during Ramadan. Furthermore, since these pa-
tients with coronary disease are at risk for thrombotic events 
including myocardial infarction, we propose the consideration 
of low-dose aspirin usage at evening meals during Ramadan 
for primary prevention of acute cardiac events in males at risk 
due to underlying non-obstructive coronary atherosclerosis. The 
rationale for this recommendation is based on conclusive ev-
idence for protecting same-aged males from first myocardial 
infarctions in the Physicians’ Health Study (PHS), a random-
ized prospective primary prevention trial (Table 1) [7]. Such us-
age is also concordant with guidelines from sub-specialty so-
cieties and the United States Preventive Service Task Force as 
determined in systematic evidence reviews [8,9].
Short-term aspirin usage has also been shown to mitigate in-
creased cardiovascular risk during inflammation associated with 
clinical conditions such as influenza, septicemia, and pre-eclamp-
sia [10–12]. The novel suggestion herein for low-dose aspirin 
usage to mitigate high short-term cardiac risk in males while 
fasting for Ramadan is similar to that proposed during severe 
infections and in susceptible males during marathons [13,14]. 
Studies on validated biomarkers for stratifying transient cardio-
vascular risk in pilgrims while observing the Hajj in Mecca dur-
ing Ramadan would provide hard data to support such usage 
as shown in asymptomatic male marathon runners (Figure 1).
•  If fasting for Ramadan transiently increases the short-term 
risk for acute myocardial ischemia in males with underlying 
non-obstructive coronary atherosclerosis
•  And aspirin use is evidence based to prevent first 
myocardial infarctions in healthy middle-aged males based 
on a randomized controlled primary prevention trial
Aspirin usage may be prudent to reduce short-term high risk 
for acute cardiovascular events in susceptible males during 
fasting for Ramadan
Table 1.  Rationale for aspirin usage to reduce acute 
cardiovascular risk during Ramadan.
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While a randomized controlled clinical trial of low-dose aspi-
rin usage in susceptible males during Ramadan lacks feasibil-
ity due to the low frequency of index events, reduction in first 
heart attacks in the PHS by 44% provides robust support for 
adopting such usage in current clinical practice. This measure 
additionally provides those at potential risk with the only med-
ication with a 1A classification for pre-hospital administration 
in the event that an acute coronary syndrome might occur.
Beyond maintaining a high index of clinical suspicion for the 
onset of angina pectoris in males observing Ramadan, this case 
serves as a springboard for recommending low-dose aspirin us-
age as an evidence-based intervention for primary cardiovas-
cular protection of susceptible males during short-term high 
risk. This clinical measure is novel, inexpensive, and readily 
available worldwide without prescription [15]. Appreciating that 
an aspirin-like remedy was known in the time of Pheidippides 
and likely prescribed by Hippocrates [16], his enduring oath to 
“first do no harm” may in the modern era be extended to also 
include not withholding treatment shown to be beneficial [17].
Conclusions
We describe herein the case of a 69-year-old male of Muslim 
Indian heritage with multiple cardiovascular risk factors who 
experienced the onset of classic angina pectoris during the 
pathophysiological stress of fasting for Ramadan. He under-
went four-vessel coronary artery bypass surgery after an acute 
myocardial infarction 3 months later while on maximal medi-
cal therapy in accordance with NICE guidelines. Based on this 
case, we propose treatment of susceptible middle-aged males 
with low-dose aspirin during fasting for Ramadan to decrease 
the risk of acute myocardial ischemia. This recommendation 
is concordant with conclusive evidence for the protection of 
same-aged healthy males from acute cardiovascular events 
in the PHS, a randomized controlled primary prevention trial.
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Figure 1.  Pilgrims at the Masjid al-Haram Mosque during the 
start of Hajj in 2008 (CC BY-SA 2.0; File: Al-Haram 
mosque – Flickr – Al Jazeera English.jpg; Created: 
4 December 2008).
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